SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001399529-20-000039
Filing Date
2020-05-07
Accepted
2020-05-07 16:15:42
Documents
18
Period of Report
2020-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K drna-20200507.htm   iXBRL 8-K 51473
2 EX-10.1 drna20200507ex101.htm EX-10.1 90394
3 EX-99.1 drna20200507ex991.htm EX-99.1 124105
4 EX-99.2 drna20200507ex992.htm EX-99.2 13419
10 dicernareports1q191.jpg GRAPHIC 22788
  Complete submission text file 0001399529-20-000039.txt   496119

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT drna-20200507.xsd EX-101.SCH 2574
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT drna-20200507_cal.xml EX-101.CAL 720
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT drna-20200507_def.xml EX-101.DEF 1657
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT drna-20200507_lab.xml EX-101.LAB 23970
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT drna-20200507_pre.xml EX-101.PRE 12656
11 EXTRACTED XBRL INSTANCE DOCUMENT drna-20200507_htm.xml XML 11143
Mailing Address 33 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 33 HAYDEN AVENUE LEXINGTON MA 02421 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 205993609 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36281 | Film No.: 20856588
SIC: 2834 Pharmaceutical Preparations